Carl Zeiss Meditec AG
Berlin, 10589, Germany
NCT Number: NCT01731743
The purpose of the study is to evaluate the far, intermediate and near visual acuities with a trifocal IOL.
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Not applicable
Berlin, 10589, Germany
After bilateral cataract surgery, monocular and binocular uncorrected (UCVA) and best distance corrected visual acuity (BCVA) will be measured at far (4m), intermediate (80 cm) and near (40 cm) distance as well as the subjective refraction.
A patient questionnaire will be used to assess the patient satisfaction and spectacle independence.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 3 months postoperatively
Monocular and binocular uncorrected and best distance corrected
Time frame: 1 and 3 month postoperatively
Monocular and binocular uncorrected and best distance corrected
Time frame: 1 and 3 month postoperatively
Carl Zeiss Meditec AG
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07735000
Age Related Cataract, Cataract
Peshawar, KPK, Pakistan
View Trial DetailsNCT07605260
Cataract, Eye Diseases
Islamabad, Punjab Province, Pakistan
View Trial DetailsNCT06428955
Cataract, Eye Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT06111222
Cataract, Eye Diseases
Heidelberg, Germany
View Trial Details